ProPhase Labs, Inc.
USD0.09
+0.00 (+1.10%)
CEO
Ted William Karkus
IPO Date
1994-04-04
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$0.09
Prev. Close
$0.09
Day Low
$0.09
Day High
$0.10
52W Low
$0.07
52W High
$6.70
Market Cap
$0.00B
Volume
0.00M
| -0.3 |
| 31 Dec 2023 | FY | 36.6% | -37.8% | -34.0% | -18.3% | 0.37 | 2.28 | -2.3 |
| 31 Dec 2022 | FY | 57.6% | 15.1% | 29.0% | 21.1% | 0.11 | 3.78 | 4.1 |
| 31 Dec 2021 | FY | 41.5% | 7.9% | 10.7% | 7.0% | 0.25 | 3.95 | 8.7 |
| 31 Dec 2020 | FY | 31.7% | -14.6% | -20.1% | -6.8% | 1.39 | 2.52 | -25.0 |
| 31 Dec 2019 | FY | 26.5% | -31.9% | -28.0% | -25.6% | 0.00 | 10.66 | -14.5 |
| 31 Dec 2018 | FY | 36.4% | -13.3% | -10.5% | -8.4% | 0.00 | 4.31 | -41.3 |
| 31 Dec 2017 | FY | 19.7% | 423.9% | 131.3% | 122.5% | 0.00 | 15.96 | 1.6 |
| 31 Dec 2016 | FY | 47.9% | -13.6% | -48.1% | -22.4% | 0.25 | 1.41 | -23.3 |
| -0.7 |
| 30 Jun 2025 | Q2 | 58.9% | -358.6% | -39.1% | -10.6% | 0.69 | 0.96 | -0.9 |
| 31 Mar 2025 | Q1 | 36.8% | 277.1% | 25.4% | 7.8% | 0.90 | 1.03 | 0.5 |
| 31 Dec 2024 | Q4 | -37.2% | 1383.2% | -467.3% | -54.4% | 3.34 | 0.95 | -0.1 |
| 30 Sept 2024 | Q3 | -5.2% | -209.4% | -17.3% | -7.2% | 0.78 | 1.47 | -0.9 |
| 30 Jun 2024 | Q2 | -19.2% | -248.7% | -14.0% | -6.6% | 0.61 | 1.58 | -1.6 |
| 31 Mar 2024 | Q1 | -11.9% | -172.4% | -14.0% | -7.0% | 0.52 | 1.88 | -2.5 |
| 31 Dec 2023 | Q4 | -87.3% | -250.1% | -17.7% | -9.5% | 0.43 | 2.28 | -1.2 |
| 30 Sept 2023 | Q3 | 27.8% | -61.5% | -9.1% | -5.6% | 0.33 | 3.04 | -1.8 |